中国麻风皮肤病杂志 ›› 2026, Vol. 42 ›› Issue (5): 366-368.doi: 10.12144/zgmfskin202605366

• 病例报告 • 上一篇    下一篇

美泊利珠单抗联合糖皮质激素治疗Wells综合征合并变应性支气管肺曲霉病一例

颜璐璐1,张婷2,余德厚1   

  1. 1贵州医科大学附属医院皮肤性病科,贵州贵阳,550001; 2贵州省人民医院皮肤性病科,贵州贵阳,550002
  • 出版日期:2026-05-15 发布日期:2026-05-11

Mepolizumab combined with glucocorticoids for Wells' syndrome complicated with allergic bronchopulmonary aspergillosis: a case report

YAN Lulu1, ZHANG Ting2, YU Dehou1   

  1. 1 Department of Dermatology and Venereology, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, China; 2 Department of Dermatology and Venereology, Guizhou Provincial People's Hospital, Guiyang 550002, China
  • Online:2026-05-15 Published:2026-05-11

摘要: 美泊利珠单抗联合糖皮质激素成功治疗Wells综合征合并变应性支气管肺曲霉病(ABPA)的病例罕有报道,本文报道一例。患者,女,24岁,全身反复皮疹伴瘙痒1个月,加重5天。患者既往有ABPA及过敏性鼻炎病史,入院后胸部CT提示双肺多发感染灶、支气管管壁增厚伴黏液栓及左肺下叶支气管扩张,外周血IgE及嗜酸性粒细胞绝对值显著升高,查体可见躯干四肢散在风团、右足踝张力性水疱,结合典型病理特征-火焰征,诊断为Wells综合征合并ABPA。给予美泊利珠单抗、糖皮质激素、伊曲康唑治疗后,皮疹及呼吸道症状好转,随访1年未复发。

关键词: 变应性支气管肺曲霉病, Wells综合征, 嗜酸性蜂窝织炎, 美泊利珠单抗

Abstract: There are rare reports on the successful treatment of Wells syndrome complicated with allergic bronchopulmonary aspergillosis (ABPA) using mepolizumab combined with glucocorticoids. This paper presents one such case. The patient was a 24-year-old female with recurrent generalized rash and pruritus for 1 month, which had aggravated for 5 days. She had a previous medical history of allergic bronchopulmonary aspergillosis (ABPA) and allergic rhinitis. After admission, chest CT showed multiple infectious foci in both lungs, bronchial wall thickening with mucus impaction, and bronchiectasis in the left lower lobe. The peripheral blood IgE and absolute eosinophil count were significantly elevated. Physical examination revealed scattered wheals on the trunk and extremities and tense blisters on the right ankle. Combined with the typical pathological feature of flame figures, a diagnosis of Wells syndrome complicated with ABPA was made. Following treatment with mepolizumab, glucocorticoids, and itraconazole, the cutaneous and respiratory symptoms improved, and no recurrence was observed during the 1-year follow-up.

Key words: allergic bronchopulmonary aspergillosis, Wells syndrome, eosinophilic cellulitis, mepolizumab